News & Press
MBC Applauds Passage of SBIR Reauthorization in US House of Representatives
Cambridge, MA
Wednesday
April 30, 2008
MBC Played Advocacy Role to Help Biotech Companies Become Eligible for Federal Grants Once Again
Massachusetts Life Sciences Initiative Legislation Clears Senate, Moves to Conference Committee
Cambridge
Wednesday
April 2, 2008
The Massachusetts Senate passed its version of the Life Sciences Initiative bill on Thursday, March 20th. The next step for the landmark Life Sciences legislation will be a review by a joint House-Senate conference committee, followed by a final report to both legislative bodies for final vote. To review both the House and senate versions of the bill, please follow the links below. You are also invited to review a "crosswalk" prepared by the MBC, which compares the two version of the legislation, side-by-side.
View the Life Sciences House bill, H. 4554, as amended.
Massachusetts Biotechnology Council: Sustaining the Biotechnology Ecosystem
Cambridge
Monday
January 7, 2008
In the Message of Hope radio series, you hear real stories of three Massachusetts researchers and a clinical trials manager who work each day to produce cures for unmet medial needs. These talented individuals come from a cross-section of the Massachusetts Biotechnology Council Membership (MBC): an academic research institution, a small biotechnology company with 15 employees, a medium sized, public biotechnology company pushing for their first product, and a large biopharmaceutical company working on its next promising therapy.
Recent Industry News
MBC In The Media
State Senate OKs Doctor Gift Ban: Boston Herald, April 19, 2008
Takeda's $8.8B for Millennium includes bonuses for workers: Boston Herald, April 11, 2008
Mass. biotech is sold for $8.8b - Japanese Drug Firm to run Millenium: Boston Globe, April 11, 2008
Murray eyes Irish gold–Trade mission to push tourism, investment: Boston Herald, April 8, 2008
Bristol-Myers job plans ahead of schedule in Devens: April 4, 2008
Genzyme Will Expand Ireland plant, Add 170 Jobs; Boston Herald, April 2, 2008
MBC Pushes Patent Reform, Biogeneric Drug Standard; Boston Business Journal, April 4, 2008
Listen to Bob Coughlin, CEO of the Massachusetts Biotechnology Council, and John Maraganore, CEO of Alnylam Pharmaceuticals in an interview on Finneran's Forum on Boston's WRKO radio station.






PHONE: 617.674.5100
EMAIL: